A cohort study of Chinese patent medicines for promoting blood circulation and removing blood stasis on stable coronary heart disease in the real world

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Meet the criteria of Western medicine diagnosis of coronary heart disease and TCM blood stasis syndrome differentiation;
•2. From January 1, 2018 to December 31, 2020, those who have been treated with Chinese patent medicines for promoting blood circulation and removing blood stasis for more than 6 months or those who only receive conventional Western medicine treatment;
•3. Age over 18 years old, no gender limit;
•4. Participate voluntarily, be able to understand and comply with the trial protocol, and sign an informed consent form.

•1. Patients with severe wasting state or malignant tumors;
•2. Women who are pregnant or breastfeeding or have pregnancy plans;
•3. Patients with severe primary diseases such as liver, kidney, hematopoietic system, or mental illness;
•4. Participants in other clinical trials in the past three months.

发起方

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University